References in periodicals archive ?
Under the co-promotion agreement, Dura's national sales and marketing organization will promote CROLOM to allergists, pediatricians and family practitioners, while Bausch & Lomb's Pharmaceutical business will focus on ophthalmologists and optometrists.
Garner stated, "As part of Dura's ongoing strategy of acquiring and marketing specialty respiratory pharmaceuticals, the addition of CROLOM will broaden the range of allergy and asthma products we offer the market.
We plan to take this opportunity to increase our sales force in order to support the promotion of CROLOM and to increase market penetration in support of our other pharmaceutical products," he stated.